)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Oxygenta Pharmaceutical
Oxygenta Pharmaceutical (524636) investor relations material
Oxygenta Pharmaceutical Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 26/27 earnings summary10 Nov, 2026
Executive summary
Q2 FY26/27 revenue from operations was Rs. 3,349.39 lakh versus Rs. 1,430.23 lakh in Q2 FY25; pre-tax loss narrowed to Rs. 339.54 lakh from Rs. 643.78 lakh.
H1 FY26/27 revenue was Rs. 7,053.44 lakh, with a pre-tax loss of Rs. 590.27 lakh and net loss of Rs. 483.90 lakh.
Financial highlights
Q2 total revenue was Rs. 3,351.41 lakh, including Rs. 2.02 lakh other income; total expenses were Rs. 3,690.96 lakh.
H1 total expenses were Rs. 7,643.71 lakh; finance costs were Rs. 518.92 lakh versus Rs. 157.80 lakh in H1 FY25/26.
Q2 net loss was Rs. 273.53 lakh; H1 net loss was Rs. 483.90 lakh, compared with Rs. 1,103.87 lakh in H1 FY25/26.
Segment performance
Operations comprise a single segment: manufacturing of pharmaceutical products; segmental reporting under Ind AS 108 was not made.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Oxygenta Pharmaceutical
- Revenue grew, losses narrowed, and post-fire recovery remained the central challenge.524636
Q4 15/16 - A ₹166.96 lakh loss accompanied a costly revival and a July 2013 production target.524636Q4 12/13
- Working-capital shortages constrained operations as FY17 losses widened to ₹5.81 crore.524636Q4 16/17
- Production resumed, but losses deepened amid heavy revival funding and significant audit and legal risks.524636Q4 13/14
- Fire-driven disruption widened FY15 losses; production resumed, with breakeven targeted for November 2015.524636Q4 14/15
- Plant restoration began after repossession, but legal and financial risks remained substantial.524636Q4 11/12
- Control was restored, but revival followed years of shutdown and extensive equipment damage.524636Q4 10/11
- A Rs 15.55 lakh FY10 loss met a revival plan after management regained the factory.524636Q4 09/10
- Factory shutdowns and disputes drove a Rs 25.34m FY06 net loss.524636Q4 05/06
Next Oxygenta Pharmaceutical earnings date
Q3 26/2714 Feb, 2027
Oxygenta Pharmaceutical
Next Oxygenta Pharmaceutical earnings date
Q3 26/2714 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Oxygenta Pharmaceutical Limited is a pharmaceutical company engaged in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on the production of bulk drugs used in various therapeutic segments, supporting pharmaceutical formulation manufacturers. Its operations include chemical synthesis, quality control, and adherence to regulatory standards for domestic and export markets. The company is headquartered in Visakhapatnam, India, and its shares are listed on the BSE.